Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients

BACKGROUND: Interferon-based therapy (IBT) has been the standard of care for hepatitis C virus (HCV) infection. However, conflicting results exist regarding the effects of IBT on risk of developing hepatocellular carcinoma (HCC) and cirrhosis-associated complications, and most included highly select...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Ching-Sheng, Huang, Chun-Jen, Kao, Jia-Horng, Lin, Hans Hsienhong, Chao, You-Chen, Fan, Yen-Chun, Tsai, Pei-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720923/
https://www.ncbi.nlm.nih.gov/pubmed/23894660
http://dx.doi.org/10.1371/journal.pone.0070458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720923/
https://www.ncbi.nlm.nih.gov/pubmed/23894660
http://dx.doi.org/10.1371/journal.pone.0070458

Ejemplares similares